On February 9th, 2007, Swiss-based computational biology provider Genedata AG announced a three-year expansion of their collaboration with the HepatoSys research network. HepatoSys, an interdisciplinary initiative funded in 2003 by leading German research centers, aims to understand the physiology and pathophysiology of the human liver cell using a systems biology approach.
In the first funding period of HepatoSys, Genedata had been tasked to develop and establish a computational platform serving as the consortium's central data storage and analysis infrastructure. The platform - built on Genedata's established products Phylosopher® and Expressionist® - was successfully deployed and is now being used by the consortium. The centralized data storage infrastructure enables an integrative approach to the interpretation of systems biology modeling results in the context of experimental findings, including high-throughput transcriptomics, proteomics and metabolomics data.
Taking the collaboration to the next level, Genedata will now work on data analysis projects to interpret the huge amounts of molecular profiling data generated within the HepatoSys consortium."After having built successfully on Genedata's track record in developing our scientific computing infrastructure, we see a tremendous opportunity in bringing together our academic expertise with Genedata's know-how to transfer systems biology applications to the pharmaceutical industry," said Prof. Jens Timmer, scientific spokesman for HepatoSys.
"The ambitous goal to simulate complex biochemical networks and their regulation in liver cells is highly relevant for innovative biomedical applications," explained Prof. Irmgard Merfort, Institute for Pharmaceutical Sciences, University of Freiburg. "Cellular processes such as programmed cell death and regeneration of liver cells are of great scientific and medical interest. Genedata will help us to identify new biomarkers for disease diagnostics and to pave the way for novel therapeutic approaches in tissue regeneration, cancer and inflammation."
Dr. Othmar Pfannes, CEO of Genedata, adds: "Genedata's contributions to concrete scientific projects show that we are considered to be a valuable partner, not only on the technical, but also on the scientific side. HepatoSys is yet another long-term relationship that proves Genedata's commitment to innovative systems biology applications".
Dr. Ute Heisner | idw
http://www.systembiologie.de or http://www.genedata.com
Designer cells: artificial enzyme can activate a gene switch
22.05.2018 | Universität Basel
Flow of cerebrospinal fluid regulates neural stem cell division
22.05.2018 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...
A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.
The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...
02.05.2018 | Event News
13.04.2018 | Event News
12.04.2018 | Event News
23.05.2018 | Physics and Astronomy
22.05.2018 | Life Sciences
22.05.2018 | Earth Sciences